Crossref
Research on risk management in clinical trials of drugs for treating Alzheimer’s disease
SCIENTIA SINICA Vitae · 01.11.2026 · 56 (11) · 2620-2635
DOI: 10.1360/ssv-2026-0124 ↗Kurz gefasst
Fachartikel in der Zeitschrift SCIENTIA SINICA Vitae, online erschienen am 03.11.2026. Verfasst von JiaJing XIA und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
XIA, J., HE, Z., LIANG, W., & CHENG, G. (2026). Research on risk management in clinical trials of drugs for treating Alzheimer’s disease. SCIENTIA SINICA Vitae, 56(11), 2620-2635. https://doi.org/10.1360/ssv-2026-0124
Vancouver
XIA J, HE Z, LIANG W, CHENG G. Research on risk management in clinical trials of drugs for treating Alzheimer’s disease. SCIENTIA SINICA Vitae. 2026;56(11):2620-2635. doi:10.1360/ssv-2026-0124
BibTeX
@article{XIA2026,
author = {XIA, JiaJing and HE, ZiQi and LIANG, WeiTing and CHENG, GuoHua},
title = {Research on risk management in clinical trials of drugs for treating Alzheimer’s disease},
journal = {SCIENTIA SINICA Vitae},
year = {2026},
volume = {56},
number = {11},
pages = {2620--2635},
doi = {10.1360/ssv-2026-0124}
}
EUVIMED